Clinical Trials Browser

Unknown × OTHER × Gynecologic × Clear all

NCT03425565 2024-04-12

PEACOCC

Phase 2 Unknown

Clear Cell Tumor

NCT05143970 2024-03-20

CHANCES

Phase 1 Unknown

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT06284980 2024-02-29

TITANIUM

Gestational Trophoblastic Disease

NCT04512209 2024-02-28

DCE-MRI

Phase NA Unknown

GastrointestinalGynecologic

Colonic Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms

NCT06031493 2024-02-28

PROVIDENCE

Phase 4 Unknown

GynecologicOther

Uterine Cervical Neoplasms, Sexual Dysfunction, Physiological

NCT06279832 2024-02-28

Romantic

Phase NA Unknown

Endometrial Neoplasms

NCT06281860 2024-02-28

PITHAC

Phase 1 Unknown

BreastGastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT05371223 2024-02-26

Nab-PIPAC

Phase 2 Unknown

GastrointestinalGynecologic

Pancreatic Neoplasms, Peritoneal Neoplasms

NCT06277947 2024-02-26

GARD-HIPEC

Phase NA Unknown

Carcinoma, Ovarian Epithelial

NCT06278636 2024-02-26

LUXA

Gynecologic Cancer

NCT05701735 2024-02-23

CECIL

Phase NA Unknown

Uterine Cervical Neoplasms, Renal Insufficiency

NCT05728814 2024-02-23

DORA

Endometrial Neoplasms

NCT06124040 2024-02-23

SUCCEEDER

Uterine Cervical Neoplasms

NCT06273878 2024-02-23

From Fetal-maternal Interface Immune Tolerance to Endometrial Cancer Immune Escape: Potential Targets for Immunotherapy

Endometrial Neoplasms

NCT05737797 2024-02-22

NIECE

Phase NA Unknown

Endometrial Neoplasms, Microsatellite Instability

NCT06273501 2024-02-22

POSVUC

Phase NA Unknown

Lymphatic Metastasis, Vulvar Neoplasms

NCT03924466 2024-02-16

VUBAR

Phase 2 Unknown

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT06263062 2024-02-16

Management With Fear of Cancer in Women Undergoing Colposcopy: Randomized Controlled Study

Phase NA Unknown

Pathophobia, Uterine Cervical Neoplasms

NCT04145388 2024-02-14

Family History Study on Cancer Risk

Phase NA Unknown

18,623 enrolled

BreastGastrointestinalGynecologic

Breast Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms, Genetic Predisposition to Disease

NCT02730923 2024-02-13

VICTORIA

Phase 1/2 Unknown

Carcinoma, Endometrial Neoplasms

NCT05829057 2024-02-13

The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

Phase 1 Unknown

GastrointestinalGenitourinaryGynecologicThoracic

Urinary Bladder Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Neoplasms, Ovarian Neoplasms, Small Cell Lung Carcinoma

NCT06250686 2024-02-09

BENITA

Phase NA Unknown

Fatigue, Muscular Atrophy, Ovarian Neoplasms, Malnutrition

NCT02820506 2024-02-08

SENTIREC II

Phase NA Unknown

Uterine Cervical Neoplasms, Uterine Neoplasms

NCT06069648 2024-02-07

Effects of Decision Aids on the Participation of South Asian Women in Cervical Cancer Screening

Phase NA Unknown

Uterine Cervical Neoplasms

NCT05189028 2024-02-06

Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer

Phase 3 Unknown

Uterine Cervical Neoplasms

NCT06243185 2024-02-06

Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid Tumors

Phase 2 Unknown

Ovarian Neoplasms

NCT06241105 2024-02-05

Lenvatinib Plus Toripalimab for Platinum-Resistant Recurrent Ovarian Cancer

Phase 2 Unknown

Ovarian Neoplasms

NCT05212779 2024-02-01

Predicting the Risk of Ovarian Cancer Recurrence Using Circulating Tumor DNA to Assess Residual Disease

Carcinoma, Ovarian Epithelial

NCT06208319 2024-02-01

IACOL

Uterine Cervical Neoplasms

NCT06236958 2024-02-01

Effect of Early Enteral Nutrition on Postoperative Recovery of Ovarian Cancer Patients

Advanced Epithelial Ovarian Cancer

NCT03016338 2024-01-30

Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer

Phase 2 Unknown

Endometrial Neoplasms

NCT04470921 2024-01-26

STOPOVCA

10,000 enrolled

Ovarian Neoplasms, Risk Reduction Behavior

NCT05489926 2024-01-26

A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure

Phase 2 Unknown

Carcinoma, Ovarian Epithelial

NCT06223763 2024-01-25

SUROVA

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT06222008 2024-01-24

Study on Symptom Clusters During Chemotherapy in Ovarian Cancer Patients With Different Chinese Medicine Constitution

Ovarian Neoplasms, Radiation Injuries, Syndrome

NCT05916690 2024-01-19

Electrochemotherapy for the Treatment of Vulvar Cancer

Phase NA Unknown

Vulvar Neoplasms

NCT05084677 2024-01-18

Toripalimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT02489006 2024-01-17

NEO

Phase 2 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05065021 2024-01-17

Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor

Phase 2 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06171581 2024-01-09

Effect of Stress Ball Use on Anxiety Level During Endometrial Biopsy Procedure

Phase NA Unknown

Endometrial Hyperplasia, Endometrial Neoplasms

NCT04683549 2024-01-08

HPV-RICCO

Phase NA Unknown

Uterine Cervical Neoplasms

NCT03935256 2023-12-18

Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer

Phase 2 Unknown

Neoplasms, Endometrial Neoplasms

NCT04675320 2023-12-07

IMMUNOPARP

Ovarian Neoplasms

NCT05049252 2023-12-07

Biomarkers Predictive for Cervical Intraepithelial Neoplasia Grade 2 (CIN2) Evolvement

Cervical Intraepithelial Neoplasia Grade 2 (CIN2)

NCT06161272 2023-12-07

Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi

Phase 2 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06155370 2023-12-04

Construction of Gynecological Tumor Organoids

Gynecologic Cancer

NCT05446324 2023-12-01

SENGA

Phase 3 Unknown

Endometrial Neoplasms

NCT04783467 2023-11-30

TREND

Phase NA Unknown

Endometrial Neoplasms

NCT05949424 2023-11-29

OPTI-DOSE

Phase 4 Unknown

BreastGenitourinaryGynecologicHead & Neck

Breast Neoplasms, Carcinoma, Renal Cell, Ovarian Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms

NCT06147960 2023-11-28

EPIcol

Uterine Cervical Neoplasms